The present study showed that RNF6 is dysregulated in more than 70% of breast cancer tissues and it is negatively associated with the survival period of breast cancer patients, which suggesting RNF6 is probably associated with its specific pathophysiological activity. The gene discussed is RNF6; the disease is breast cancer.